Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. PHSYX: which is better?

Bottom line

XLV vs PHSYX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PHSYX (Putnam Global Health Care Fund) share a meaningful slice of their top holdings — about 67% by weight.

XLV is cheaper at 0.08% vs 0.79% — a difference of $71 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +8.1% for PHSYX (reporting dates differ).

Updated Nov 19, 2026

XLV vs PHSYX side by side

XLVPHSYX
TypeETFMutual fund
Fund familySPDR (State Street)Franklin Templeton
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.79%
Annual cost per $10k$8$79
10-yr cost on $10k (prospectus)$103$978
Max front loadNone0%
12b-1 fee0.02%0%
1-yr return+14.5%+1.5%
5-yr return (annualized)+8.1%+8.1%
10-yr return (annualized)+9.8%+7.8%
Best quarter+14.5%—
Worst quarter−12.7%—
Net assets (fund)$40.6B$1.5B
Number of holdings65115
Portfolio turnover2%67%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of XLV's top 25 holdings also appear in PHSYX's top 25.

Shared top holdings
HoldingXLVPHSYX
Eli Lilly & Co16.51%13.15%
Johnson & Johnson10.64%8.46%
AbbVie Inc7.74%6.05%
UnitedHealth Group Inc6.57%6.93%
Merck & Co Inc5.52%4.88%
Amgen Inc3.40%1.11%
Thermo Fisher Scientific Inc3.24%4.50%
Gilead Sciences Inc2.73%2.63%
Intuitive Surgical Inc2.45%4.04%
CVS Health Corp2.30%2.74%
Vertex Pharmaceuticals Inc2.19%1.97%
Bristol-Myers Squibb Co2.05%1.75%
McKesson Corp1.58%2.14%
Boston Scientific Corp1.10%1.80%
HCA Healthcare Inc1.05%1.18%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

PHSYX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

FAQ

What is the difference between XLV and PHSYX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PHSYX (Putnam Global Health Care Fund) share a meaningful slice of their top holdings — about 67% by weight. XLV is cheaper at 0.08% vs 0.79% — a difference of $71 a year per $10,000 invested.
Which is cheaper, XLV or PHSYX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and PHSYX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.